Arterial, portal, or systemic chemotherapy for patients with hepatic metastasis of colorectal carcinoma

Journal of Hepato-Biliary-Pancreatic Surgery

Volumn 6, Issue 1, 1999, Pages 39-49

  Kemeny, Nancy ^a   Fata, Farid ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADENOCARCINOMA; COLORECTAL TUMOR; CONTROLLED CLINICAL TRIAL; DISEASE FREE SURVIVAL; FEMALE; HEPATIC ARTERY; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER TUMOR; MALE; METASTASIS; METHODOLOGY; MORTALITY; PATHOLOGY; PORTAL VEIN; REGIONAL PERFUSION; REVIEW; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE;

ADENOCARCINOMA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COLORECTAL NEOPLASMS; CONTROLLED CLINICAL TRIALS; DISEASE-FREE SURVIVAL; FEMALE; HEPATIC ARTERY; HUMANS; INFUSIONS, INTRA-ARTERIAL; INFUSIONS, INTRAVENOUS; LIVER NEOPLASMS; MALE; PORTAL VEIN; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE;

EID: 0032601767     PISSN: 09441166     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005340050082     Document Type: Article

References (85)

1. Coller FA (1956) Cancer of the colon and rectum. American Cancer Society, New York
2. Kemeny N, Lokich JJ, Anderson N, Ahlgren JD (1993) Recent advances in the treatment of advanced colorectal cancer. Cancer 71:9-18
3. Kemeny N, Yagoda A, Braun D Jr, Golbey R (1980) Therapy for metastatic colorectal carcinoma with a combination of methyl-CCNU, 5-fluorouracil, vincristine and streptozotocin (MOF-strep). Cancer 45:876-881
4. Baker LH, Talley RW, Matter R, Lehane DE, Ruffner BW, Jones SE, Morrison FS, Stephens RL, Gehan EA, Vaitkevicius VK (1976) Phase III comparison of the treatment of advanced gastrointestinal cancer with bolus weekly 5-FU vs methyl CCNU plus bolus weekly 5-FU. Cancer 38(1):1-7
5. Grage TB, Vassilopoulos PP, Shingleton WW, Jubert AV, Elias EG, Aust JB, Moss SE (1979) Results of a prospective randomized study of hepatic artery infusion with 5-fluorouracil vs intravenous 5-fluorouracil in patients with hepatic metastases from colorectal cancer: A Central Oncology Group Study. Surgery 86:550-555
6. Buyroker T, Kim PN, Groppe C, McCracken J, O'Bryan R, Panettiere F, Coltman C, Bottomley R, Wilson H, Bonnet J, Thigpen T, Vaitkevicius VK, Hoogstraten B, Heilbrun L (1978) 5-FU infusion with methyl-CCNU in the treatment of advanced colon cancer. Cancer 42:1228
7. Kemeny N, Yagoda A, Braun D Jr, Golbey R (1979) A randomized study of two different schedules of methyl CCNU, 5-FU and vincristine for metastatic colorectal carcinoma. Cancer 43:78-82
8. Kemeny N, Younes A, Seiter K, Kelsen D, Sammarco P, Adams L, Derby S, Murray P, Houston C (1990) Combination fluorouracil (FU) and recombinant alpha-interferon (lfn) in advanced colorectal carcinoma: Activity but significant toxicity. Cancer 66:2470-2475
9. Wadler S, Schwartz EL, Goldman M, Lyver A, Rader M, Zimmerman M, Itri L, Weinberg V, Wiernik PH (1989) Fluorouracil and recombinant alpha-2a-interferon: An active regimen against advanced colorectal carcinoma. J Clin Oncol 7:1769-1775
10. De Gramont A, Vignoud J, Tournigand C, Louvet C, Andre T, Varette C, Raymond E, Moreau S, Le Bail N, Krulik M (1997) Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer. Eur J Cancer 3:214-219
11. Petrelli N, Douglass HO, Herrera L, Russell D, Stablein DM, Bruckner HW, Mayer RJ, Schinella R, Green MD, Muggia FM (1989) The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: A prospective randomized phase III trial. J Clin Oncol 7:1419-1426
12. Rougier P, Bugat R, Douillard JY, Culine S, Suc E, Brunet P, Becouarn Y, Ychou M, Marty M, Extra JM, Bonneterre J, Adenis A, Seitz JF, Ganem G, Namer M, Conroy T, Negrier S, Merrouche Y, Burki F, Mousseau M, Herait P, Mahjoubi M (1997) Phase II Study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naïve patients and patients pretreated with fluorouracil-based chemotherapy. J Clin Oncol 15:251-260
13. Conti J, Kemeny N, Saltz LB, Huang Y, Tong WP, Chou TC, Sun M, Pulliam S, Gonzalez C (1996) Irinotecan is an active agent in untreated patients with metastatic colorectal cancer. J Clin Oncol 14:709-715
14. Rotheberg M, Eckardt J, Kuhn J (1996) Phase II trial of irinotecan in patients with progress of rapidly recurrent colorectal cancer. J Clin Oncol 14:1128-1135
15. Pitot H, Wender D, O'Connell MJ, Schroeder G, Goldberg RM, Rubin J, Mailliard JA, Knost JA, Ghosh C, Kirschling RJ, Levill R, Windschitl HE (1997) Phase II trial of irinotecan in patients with metastatic colorectal carcinoima. J Clin Oncol 15:2910-2919
16. Glimelius B, Hoffman K, Olafsdottir M, Pahlman L, Sjoden PO, Wennberg A (1989) Quality of life during cytostatic therapy for advanced symptomatic colorectal carcinoma: A randomized comparison of two regimens. Eur J Cancer Clin Oncol 25:829-835
17. Scheithauer W, Rosen H, Kornek G-V, Sebesta C, Depisch D (1993) Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. BMJ 306:752-755
18. Que FG, Nagorney DM (1994) Resection of "recurrent" colorectal metastases to the liver. Br J Surg 81:255-258
19. Breedis C, Young C (1954) The blood supply of neoplasms in the liver. Am J Pathol 30:969
20. Ensminger WD, Rosowsky A, Raso V (1978) A clinical pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2-deoxyuridine and 5-fluorouracil. Cancer Res 38:3784-3792
21. Van Groeningen CJ, Van derVijgh WJ, Giaccone G, Kedde M, Gall HE, Bart M, Pinedo HM (1997) Phase I clinical and pharmacokinetic study of 5-day CPT-11 hepatic arterial infusion (HAI) chemotherapy (meeting abstract). Proc ASCO 16: A768
22. van Tellingen O, Kuck M, Vlasveld LT, Rodenhuis S, Nooijen WJ, Beijnen JH (1996) Unchanged pharmacokinetics of etoposide given by intra-arterial hepatic infusion as compared with i.v. infusion. Cancer Chemother Pharmacol 38:387-390
23. Tandon RN, Bunnell IL, Copper RG (1973) The treatment of metastatic carcinoma of the liver by percutaneous selective hepatic artery infusion of 5-fluorouracil. Surgery 73:118
24. Ansfield FJ, Ramirez G, Davis HL Jr, Wirtanen GW, Johnson RO, Bryan GT, Manalo FB, Borden EC, Davis TE, Esmili M (1975) Further clinical studies with intrahepatic arterial infusion with 5-fluorouracil. Cancer 36:2413-2417
25. Watkins E Jr, Khazei AM, Nahra KS (1970) Surgical basis for arterial infusion chemotherapy of disseminated carcinoma of the liver. Surg Gynecol Obstet 130:581
26. Cady B, Oberfield RA (1974) Regional infusion chemotherapy of hepatic metastases from carcinoma of the colon. Am J Surg 127:220-227
27. Smiley S, Schouten J, Chang A (1981) Intrahepatic arterial infusion with 5-FU for liver metastases of colorectal carcinoma. Proc ASCO 22:391
28. Metzger U, Weder W, Rothlin M, Largiader F (1991) Phase II study of intra-arterial fluorouracil and mitomycin-C for liver metastases of colorectal cancer. Recent Results Cancer Res 121:198-204
29. Denck H (1984) Ergebnisse einer intraarteriellen intermittierenden Chemotherapie mit 5-FU bei Metastasenleber sowie inoperablen Tumoren des Gastrointestinal-und Urogenitaltrakts. Onkologie 7:167-176
30. Schlag P, Hohenberger P, Holting T (1990) Hepatic arterial infusion (HAI) chemotherapy for liver metastases of colorectal cancer using 5-FU. Eur J Surg Oncol 16:99-104
31. Rougier P, Laser P, Elias D (1987) Intraarterial hepatic chemotherapy (IAHC) for liver metastases (LM) from colorectal (CR) origin (abstract) Proc ASCO 6:369
32. Borner M, Laffer U, Ludwig C, Obrist R, Metzger U, Aeberhard P, Weber W, Castiglione M, Obrecht JP, Brunner K (1990) Effectiveness and low toxicity of hepatic artery infusion with fluorouracil and mitomycin for metastatic colorectal cancer confined to the liver. From the Swiss Group for Clinical and Epidemiological Cancer Research (SAKK). Ann Oncol 1:227-228
33. Civalleri D, DeCian F, Pellicci R, Balletto N, Simoni G, Cosimelli M, Mondini G, Bignami P, Cagol PP (1998) Differential device performances for hepatic arterial chemotherapy: A technical report on totally implantable pumps and ports for both continuous and bolus infusion. Eur Surg Res 30:26-33
34. Niederhuber JE, Ensminger W, Gyves J, Thrall J, Walker S, Cozzi E (1984) Regional chemotherapy of colorectal cancer metastatic to the liver. Cancer 53:1336
35. Balch CM, Urist MM (1986) Intra-arterial chemotherapy for colorectal liver metastases and hepatomas using a totally implantable drug infusion pump. Recent Results Cancer Res 100:123-147
36. Kemeny N, Daly J, Oderman P, Shike M, Chun H, Petroni G, Geller N (1984) Hepatic artery pump infusion toxicity and results in patients with metastatic colorectal carcinoma. J Clin Oncol 2:595-600
37. Shepard KV, Levin B, Karl RC, Faintuch J, DuBrow RA, Hagle M, Cooper RM, Beschorner J, Stablein D (1985) Therapy for metastatic colorectal cancer with hepatic artery infusion chemotherapy using a subcutaneous implanted pump. J Clin Oncol 3:161
38. Cohen AM, Kaufman SD, Wood WC, Greenfield AJ (1983) Regional hepatic chemotherapy using an implantable drug infusion pump. Am J Surg 145:529-533
39. Weiss GR, Garnick MB, Osteen RT, Steele GD Jr, Wilson RE, Schade D, Kaplan WD, Boxt LM, Kandarpa K, Mayer RJ (1983) Long-term arterial infusion of 5-fluorouracil for liver metastases using an implantable infusion pump. J Clin Oncol 1:337-344
40. Schwartz SI, Jones LS, McCune CS (1985) Assessment of treatment of intrahepatic malignancies using chemotherapy via an implantable pump. Ann Surg 201:560-567
41. Johnson LP, Wasserman PB, Rivkin SE (1983) FUDR hepatic arterial infusion via an implantable pump for treatment of hepatic tumors. Proc ASCO 2:119
42. Kemeny M, Battifora H, Blayney DW, Cecchi G, Goldberg DA, Leong LA, Margolin KA, Terz JJ (1985) Sclerosing cholangitis after continuous hepatic artery infusion of FUDR. Ann Surg 202:176
43. Kemeny N (1992) Is hepatic infusion chemotherapy effective treatment for liver metastases? Yes. In: DeVita V, Hellman S, Rosenberg S (eds) Important advances in oncology. J.B. Lippincott, Philadelphia, pp 207-227
44. Hohn DC, Stagg RJ, Friedman MA, Hannigan JF Jr, Rayner A, Ignoffo RJ, Acord P, Lewis BJ (1989) A randomized trial of continuous intravenous versus hepatic intra-arterial floxuridine in patients with colorectal cancer metastatic to the liver (the Northern California Oncology Group Trial). J Clin Oncol 17:1646
45. Kemeny N, Daly J, Reichman B, Geller N, Botet J, Oderman P (1987) Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. Ann Int Med 107:459-465
46. Kemeny N, Braun DW (1983) Prognostic factors in advanced colorectal carcinoma: The importance of lactic dehydrogenase, performance status, and white blood cell count. Am J Med 74:786-794
47. 45a. Kemeny N, Niedzwiecki D, Shurgot B, Oderman P (1989) Prognostic variables in patients with hepatic metastases from colorectal cancer. Cancer 63:130
48. Hohn D, Stagg R, Friedman M (1989) A randomized trial of continuous intravenous versus hepatic intra-arterial floxuridine in patients with colorectal cancer metastatic to the liver: The Northern California Oncology Group Trial. J Clin Oncol 7:1646-1654
49. Chang AE, Schneider PD, Sugerbaker PH (1987) A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 206:685-693
50. Martin JK Jr, O'Connell MJ, Wieand HS, Fitzgibbons RJ Jr, Mailliard JA, Rubin J, Nagorney DM, Tschetter LK, Krook JE (1990) Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial. Arch Surg 125:1022
51. Rougier P, Laplanche A, Huguier M, Hay JM, Ollivier JM, Escat J, Salmon R, Julien M, Roullet Audy JC, Gallot D (1992) Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. J Clin Oncol 10:1112-1118
52. Allen-Mersh TG, Earlam S, Fordy C, Abrams K, Houghton J (1994) Quality of life and survival with continuous hepatic artery floxuridine infusion for colorectal liver metastases. Lancet 344:1255-1260
53. Lorenz M, Staib-Sebler E, Koch B, Gog C, Waldeyer M, Encke A (1997) The value of postoperative hepatic arterial infusion following curative liver resection. Anticancer Res 17:3825-3834
54. Nonami T, Takeuchi Y, Yasui M, Kurokawa T, Taniguch K, Harada A, Nakao A, Takagi H (1997) Regional adjuvant chemotherapy after partial hepatectomy for metastatic colorectal carcinoma. Semin Oncol 24 [Suppl 6]:56-130
55. Kemeny N, Seiter K, Conti JA, Sigurdson ER, Tao Y, Niedzwiecki D, Botet J, Budd A (1993) Randomized trial of hepatic arterial FUDR, mitomycin and BCNU versus FUDR alone: Effective salvage therapy for liver metastases of colorectal cancer. J Clin Oncol 11:330
56. 53a. Kemeny N, Seiter K, Niedzwiecki D, Chapman D, Sigurdson E, Cohen A, Botet J, Oderman P, Murray P (1992) A randomized trial of intrahepatic infusion of fluorodeoxyuridine (FUDR) with dexamethasone versus FUDR alone in the treatmen of metastatic colorectal cancer. Cancer 69:327-334
57. Kemeny N, Conti J, Blumgart L (1995) Hepatic arterial infusion oif floxuridine (FUdR), dexamethasone (Dex) and high dose mitomycin-C: Comparable response to FUdR/lleucovorin/ Dex but with greater toxicity (abstract). Proc ASCO vol 14, abs 480; pp 201
58. Kemeny N, Cohen A, Bertino JR, Sigurdson ER, Botet J, Oderman P (1990) Continuous intrahepatic infusion of floxuridine and leucovorin through an implantable pump for the treatment of hepatic metastases from colorectal carcinoma. Cancer 65:2446-2450
59. Kemeny N, Seiter K, Conti JA, Cohen A, Bertino JR, Sigurdson ER, Botet J, Chapman D, Mazumdar M, Budd AJ (1994) Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. Cancer 73:1134-1142
60. Kemeny N, Conti J, Cohen A, Campana P, Huang Y, Shi WJ, Botet J, Pulliam S, Bertino JR (1994) A Phase II study of hepatic arterial FUDR, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma. J Clin Oncol 12:2288-2295
61. Mariani G, Di Sacco S, Bonini R, Di Luca L, Buralli S, Bonora D, Ricci S, Baranowska-Kortylewicz J, Adelstein SJ, Falcone A, Kassis AI (1996) Biochemical modulation by 5-fluorouracil and 1-folinic acid of tumor uptake of intra-arterial 5-[123 I] iodo-2′-deoxyuridine in patients with liver metastases from colorectal cancer. Acta Oncol 35:941-945
62. Taton G, Ghanem G, Pandin P, Goldzarian J, Thaysse C, Bertin L, Ickx B, Medhi A, Salari A, Vanherweghem JL, Lambilliotte JP (1996) First results of a clinical pilot study on intra-arterial chemotherapy with haemofiltration of locally advanced gastrointestinal cancers. Acta Chir Belg 96:206-210
63. Robertson JM, McGinn CJ, Walker S, Marx MV, Kessler ML, Ensminger WD, Lawrence TS (1997) A phase I trial of hepatic arterial bromodeoxyuridine and conformal radiation therapy for patients with primary hepatobiliary cancers or colorectal liver metastases. Int J Rad Oncol Biol Phys 39:1087-1092
64. Okuno K, Shigeoka H, Lee YS, Son E, Kayama H, Nakai T, Koh K, Yasutomi M (1996) Adjuvant hepatic arterial IL-2 and MMC, 5-FU after curative resection of colorectal liver metastases. Hepatogastroenterology 43:688-691
65. Arisawa Y, Sutanto-Ward E, Fortunato L, Sigurdson ER (1995) Hepatic artery dexamethasone infusion inhibits colorectal hepatic metastases: A regional antiangiogenic therapy. Ann Surg Oncol 2:114-120
66. Lorenz M, Staib-Sebler E, Gog C, Petrowsky H, Kohne CH, Encke A (1998) A pilot study on intensive weekly 24-hour intra-arterial infusion with 5-fluorouracil and folinic acid for colorectal liver metastases. Oncology 55:53-58
67. Kornmann M, Link KH, Lenz HJ, Pillasch J, Metzger R, Butzer U, Leder GH, Weindel M, Safi F, Danenberg KD, Beger HG, Danenberg PV (1997) Thymidylate synthase is a predictor for response and resistance in hepatic artery infusion chemotherapy. Cancer Lett 118:29-35
68. Kemeny N, Daly J, Reichman B, Geller N, Botet J, Oderman P (1987) Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. Ann Intern Med 107:459-465
69. Niederhuber JE (1985) Arterial chemotherapy for metastatic colorectal cancer in the liver. In: Proceedings of Conference on advances in regional Cancer therapy, Giessen, West Germany
70. Wagman LD, Kemeny MM, Leong L, Terz JJ, Hill LR, Beatty JD, Kokal WA, Riihimaki DU (1990) A prosptive randomized evaluation of the treatment of colorectal cancer metastatic to the liver. J Clin Oncol 8:1885-1893
71. Van Ooijen B, Wiggers T, Meijer S, van der Heijde MN, Slooff MJ, van de Velde CJ, Obertop H, Gouma DJ, Bruggink ED, Lange JF (1992) Hepatic resections for colorectal metastases in The Netherlands - a multi-institutional 10-year study. Cancer 70:28-34
72. Kornmann M, Link KH, Lenz HJ, Pillasch J, Metzger R, Butzer U, Leder GH, Weindel M, Safi F, Danenberg KD, Beger HG, Danenberg PV (1997) Thymidylate synthase is a predictor for response and resistance in hepatic artery infusion chemotherapy. Cancer Lett 118:29-35
73. Dukes CE (1957) Discussion on major surgery in carcinoma of the rectum, with and without colostomy, excluding the anal canal and including the rectosigmoid. Proc R Soc Med 50:1031-1043
74. Fisher ER, Turnbull RB Jr (1955) The cytologic demonstration and significance of tumor cells in the mesenteric venous blood in patients with colorectal carcinoma. Surg Gynecol Obstet 100:102-108
75. Ackerman NB (1974) The blood supply of experimental liver metastases. IV. Changes in vascularity with increasing tumor growth. Surgery 2:589-597
76. Basserman R (1986) Changes of vascular pattern of tumors and surrounding tissue during different phases of metastatic growth. Cancer Res 100:256-264
77. Almersjo O, Brandberg, Gustavsson B (1975) Concentration of biologically active 5-fluorouracil in general circulation during continuous portal infusion in man, a preliminary report. Cancer Lett 1:113-118
78. Taylor I, Machin D, Mullee M, Trotter G, Cooke T, West C (1979) Adjuvant cytotoxic liver perfusion for colorectal cancer. Br J Surg 66:833-837
79. Taylor I, Machin D, Mullee M (1985) A randomized controlled trial of adjuvant portal vein cytotoxic parfusion in colorectal cancer. Br J Surg 72:359-362
80. Weber W, Laffer U, Metzger U (1993) Adjuvant portal liver infusion with 5-fluorouracil and mitomycin in colorectal cancer. Anticancer Res 13:1839-1849
81. Wolmark N, Rockette H, Wickerham DL, Fisher B, Redmond C, Fisher ER, Potvin M, Davies RJ, Jones J, Robidoux A (1990) Adjuvant therapy of Dukes' A, B and C adenocarcinoma of the colon with portal-vein fluorouracil hepatic infusion: Preliminary results of national surgical adjuvant breast and bowel project protocol C-02. J Clin Oncol 8:1466-1475
82. Gray B, deZwart J, Fisher R (1987) The Australia and New Zealand trial of adjuvant chemotherapy in colon cancer. In: Jones S, Salmon S (eds) Adjuvant therapy of cancer. Grune and Stratton, New York, pp 537-546
83. Swiss Group for Clinical Cancer Research (1995) Long term results of single course of adjuvant intraportal chemotherapy for colorectal cancer. Lancet 345:349-352
84. Arisawa Y, Ward-Sutanto E, Fortunato L, Sigurdsin E (1995) Hepatic artery dexamethasone infusion inhibits colorectal hepatic metastases: A regional antiangiogenic therapy. Ann Surg Oncol 2:114-120
85. Beart RW, Moertel CG, Weiand HS, Leigh JE, Windschitl HE, Van Heerden JA, Fitzgibbons RJ Jr, Wolff BG (1990) Adjuvant therapy for resectable colorectal carcinoma with fluorouracil administered by portal vein infusion. A study of the Mayo Clinic and the North Central Cancer Treatment Group. Arch Surg 125:897-901